Latest filing published 31 Mar 2022 for Endo International plc, €19k.
Blaise Coleman, listed as chief executive, appears in our data through filings on Endo International plc shares, published by SEC (Form 4). Over a trading history stretching from 21 February 2019 to 29 March 2022, the count stands at 16 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 31 March 2022 with a share grant (€19k) in Endo International plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations